Wegovy Pill Launch Shows Strong Early Success
Novo Nordisk's pill version of the blockbuster weight loss drug Wegovy is launching with impressive momentum. The oral alternative to injections could make life-changing treatment easier for millions.
Search
Find uplifting stories about heroes, innovations, and solutions
92 results for "wegovy"
Weight Loss Drug Wegovy May Fight Arthritis Inflammation
Scientists discovered that popular weight loss medications like Wegovy might one day treat arthritis by fighting inflammation directly inside joints. This breakthrough could transform how millions manage painful joint conditions.
FDA Approves Higher-Dose Wegovy for Greater Weight Loss
A new, more powerful version of Wegovy just got FDA approval and could help people who haven't reached their weight loss goals with standard doses. The higher-dose shot helped study participants lose an extra 8 pounds on average.
FDA Approves Higher Dose Wegovy for Weight Loss Treatment
A new, stronger version of the popular weight loss medication Wegovy just got FDA approval, giving more Americans access to potentially more effective obesity treatment. The approval came through a new fast-track program designed to speed up medicines that address major health priorities.
Weight Loss Drugs: Many Keep Pounds Off After Stopping
New real-world data shows many patients who stop taking popular weight loss drugs like Wegovy and Zepbound don't quickly regain the weight they lost. The findings challenge earlier concerns that the benefits disappear when treatment ends.
Generic Wegovy Could Cost Just $3 a Month Starting 2026
Life-changing weight loss and diabetes drugs could soon be made for as little as $3 per month, making them affordable for millions who've been priced out. Patents expire this month in several countries, opening the door to low-cost versions.
Weight Loss Patients Keep Pounds Off With Fewer GLP-1 Shots
People taking weight loss drugs like Wegovy are successfully maintaining their results by spacing out injections to every two weeks instead of weekly. A new study shows most patients kept the weight off and their health improvements without weekly shots.
Weight Loss Patients Thrive on Fewer GLP-1 Injections
People using GLP-1 weight loss medications may not need weekly injections forever. A new study shows many patients maintain their weight loss while spacing out doses to every two or even six weeks.
GLP-1 Drugs Help Hearts and Livers Without Weight Loss
New research shows popular weight loss drugs like Wegovy help prevent heart attacks and heal liver disease even in people who don't lose pounds. This discovery could change how millions access life-saving treatment.
GLP-1 Drugs Help Hearts and Livers Beyond Weight Loss
New research reveals that GLP-1 medications like Wegovy improve heart and liver health even in patients who don't lose weight. The discovery could help millions more people access these life-changing drugs.
Weight Loss Drug Goes Generic for 3 Billion People
Starting this weekend, affordable generic versions of Ozempic and Wegovy will reach countries representing 40% of the world's population. Prices could eventually drop to $15 per month, making the life-changing medication accessible to millions who couldn't afford it before.
France Covers Weight-Loss Drugs for 10M Citizens
Starting June 15, France becomes Europe's first country to fully reimburse medications like Wegovy and Mounjaro. Nearly 10 million French citizens struggling with obesity will now access treatments that previously cost €300 per month.
Two New Ways to Keep Weight Off After Diets and GLP-1 Drugs
Scientists have found two promising methods to help people maintain their weight loss after stopping diets or GLP-1 medications like Wegovy. New research shows a daily pill and a probiotic supplement can both help prevent the frustrating cycle of weight regain.
Tiny Implant Could Help Weight Loss Patients Stay on Track
A new under-the-skin implant might solve the biggest challenge facing weight loss patients: staying on treatment long enough to keep pounds off. The device delivers steady doses of the same medicine in Ozempic and Wegovy, potentially reducing side effects and making treatment easier.
What to Do After Reaching Your Weight Loss Goal on GLP-1s
Millions of Americans have lost significant weight using GLP-1 medications like Ozempic and Wegovy, but keeping it off requires a smart, sustainable plan. Here's the hopeful science behind maintaining your success.
Weight-Loss Drugs Linked to 30% Lower Breast Cancer Risk
Popular medications like Ozempic and Wegovy may do more than help people lose weight. A study of over 110,000 women found those taking these drugs had a 30% lower risk of developing breast cancer.
New Weight Loss Drugs Silence 'Food Noise' for Millions
People taking obesity medications like Ozempic and Wegovy report a surprising benefit: the constant mental chatter about food has completely disappeared. Scientists think this discovery could unlock the mystery of what causes obesity.
Weight-Loss Drugs May Preserve Muscle Better Than Feared
New research challenges concerns that popular GLP-1 medications like Wegovy and Zepbound cause excessive muscle loss. The findings offer reassurance to millions considering or using these breakthrough weight-loss treatments.
Diabetes Drug Semaglutide Cuts Depression Worsening by 42%
A breakthrough study of 95,000 patients found that semaglutide, the active ingredient in Ozempic and Wegovy, significantly reduces the risk of worsening mental health in people with diabetes and depression. The discovery could offer hope for millions living with both conditions.
Weight Loss Drug Regrows Cartilage in Arthritis Patients
Scientists discovered that semaglutide, the drug behind Ozempic and Wegovy, can rebuild damaged cartilage in people with arthritis even without weight loss. The breakthrough hints at a powerful new treatment for millions suffering from joint pain.
Showing 20 of 92